Treatment of anxiety disorders in alcohol abusers

Sivolap Iu.P.

doi:https://doi.org/10.17116/jnevro20181181234-38

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Treatment of anxiety disorders in alcohol abusers

Authors:

Sivolap Iu.P.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(1‑2): 34‑38

DOI: 10.17116/jnevro20181181234-38

Read: 4449 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Sivolap IuP. Treatment of anxiety disorders in alcohol abusers. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(1‑2):34‑38. (In Russ.)
https://doi.org/10.17116/jnevro20181181234-38

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Pathogenetic interrelations of hypogonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23

The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104

Clinical and psychopathological features of treatment-resistant schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50

The state of mental health of migrant workers and citizens of the Russian Federation: A comparative analysis as illustrated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101

Depression Anxiety Stress Scale (russian language version). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):103-107

Chronic obstructive pulmonary disease (COPD 2024). Clinical guidelines (short version). Journal of Respiratory Medicine. 2025;(2):5-16

Dysfunctional pelvic pain in women. Russian Journal of Pain. 2025;(2):32-37

Neuropathic pain in chronic inflammatory demyelinating polyneuropathies: analysis of 64 cases. Russian Journal of Pain. 2025;(2):45-53

Effect of polymorphic variants of the HTR2A gene on the effectiveness and safety of sertraline in patients with mixed anxiety-depressive disorder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):75-84

Psychodermatological aspects of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):403-411

Abstract:

The tendency to anxiety is a characteristic feature of alcohol abusers, and anxiety can be a symptom of alcohol withdrawal as well as comorbid disorder. The frequent comorbidity of alcohol use disorders and anxiety is due to a number of reasons including general hereditary predisposition, mutual conditioning and similar pathogenesis. Pharmacological therapy of anxiety disorders in alcohol-dependent patients is carried out on the basis of general principles of anxiety treatment and involves the use of benzodiazepines, antidepressants and, in some cases, antipsychotics as second-line medicines.

Keywords:

alcohol use disorders; anxiety; alcohol withdrawal; amygdala; benzodiazepines; antidepressants; selective serotonin reuptake inhibitors; antipsychotics

Authors:

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Close metadata

References:

Petit G, Luminet O, Cordovil de Sousa Uva M, Monhonval P, Leclercq S, Spilliaert Q, Zammit F, Maurage P, de Timary P. Gender differences in affects and craving in alcohol-dependence: a study during alcohol detoxification. Alcohol Clin Exp Res. 2017;41(2):421-431. https://doi.org/10.1111/acer.13292
Marquenie LA, Schadé A, van Balkom AJ, Comijs HC, de Graaf R, Vollebergh W, van Dyck R, van den Brink W. Origin of the comorbidity of anxiety disorders and alcohol dependence: findings of a general population study. Eur Addict Res. 2007;13(1):39-49. https://doi.org/10.1159/000095814
Khantzian EJ, Mack JE, Schatzberg AF. Heroin use as an attempt to cope: clinical observations. Am J Psychiatry. 1974;131(2):160-164. https://doi.org/10.1176/ajp.131.2.160
Crum RM, La Flair L, Storr CL, Green KM, Stuart EA, Alvanzo AA, Lazareck S, Bolton JM, Robinson J, Sareen J, Mojtabai R. Reports of drinking to self-medicate anxiety symptoms: longitudinal assessment for subgroups of individuals with alcohol dependence. Depress Anxiety. 2013;30(2):174-183. https://doi.org/10.1002/da.22024
Le TL, Levitan RD, Mann RE, Maunder RG. Childhood adversity and hazardous drinking: the mediating role of attachment insecurity. Subst Use Misuse. 2018;15:1-12. https://doi.org/10.1080/10826084.2017.1409764
Uhlmann A, Bandelow B, Stein DJ, Bloch S, Engel KR, Havemann-Reinecke U, Wedekind D. Grey matter structural differences in alcohol-dependent individuals with and without comorbid depression/anxiety-an MRI study. Eur Arch Psychiatry Clin Neurosci. 2018. https://doi.org/10.1007/s00406-018-0870-x
Dom G, Moggi F. (Editors). Co-occurring Addictive and Psychiatric Disorders. A Practice-Based Handbook from a European Perspective. Berlin: Springer; 2015.
Roberto M, Gilpin NW, Siggins GR. The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb Perspect Med. 2012;2(12):012195. https://doi.org/10.1101/cshperspect.a012195
Olsen RW, Liang J. Role of GABAA receptors in alcohol use disorders suggested by chronic intermittent ethanol (CIE) rodent model. Mol Brain. 2017;10(1):45. https://doi.org/10.1186/s13041-017-0325-8
Gilpin NW, Herman MA, Roberto M. The central amygdala as an integrative hub for anxiety and alcohol use disorders. Biol Psychiatry. 2015;77(10):859-869. https://doi.org/10.1016/j.biopsych.2014.09.008
Schatzberg A, DeBattista C. Manual of Clinical Psychopharmacology (Eight Edition). Washington, DC: American Psychiatric Publishing; 2015.
Taylor D, Paton C, Kapur S. The Maudsley Prescribing Guidelines in Psychiatry (Eleventh Edition). Chichester: Wiley-Blackwell; 2012.
Long D, Long B, Koyfman A. The emergency medicine management of severe alcohol withdrawal. Am J Emerg Med. 2017;35(7):1005-1011. https://doi.org/10.1016/j.ajem.2017.02.002
Semple D, Smyth R. Oxford Handbook of Psychiatry (Third Edition). Oxford: Oxford University Press; 2013.
Zobin ML. Terapevticheskie vmeshatel’stva v addiktologii. Prakticheskoe rukovodstvo dlya vrachei. M.: Knorus; 2018. (In Russ.)
Avedisova AS. On the question of dependence on benzodiazepines. Psikhiatriya i psikhofarmakoterapiya im. P.B. Gannushkina. 1999;1:24-26. (In Russ.)
Kattimani S, Bharadwaj B, Arun AB. Benzodiazepine maintenance for alcohol dependence: a case series. J Family Med Prim Care. 2017;6(2):431-433. https://doi.org/10.4103/2249-4863.220038
Fitzgerald KT, Bronstein AC. Selective serotonin reuptake inhibitor exposure. Top Companion Anim Med. 2013;28(1):13-17. https://doi.org/10.1053/j.tcam.2013.03.003
Pribytkov AA. The efficacy of benzodiazepines and low-potent antipsychotics as adjunctive therapy of somatoform disorders. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2016;116(5):52-56. (In Russ.) https://doi.org/10.17116/jnevro20161165152-56
Yakhno NN, Parfenov VA, Reyhart DV, Belostotsky AV, Arnautov VS. The multicenter non-interventional, prospective observational program on the study of practical use of teraligen in patients diagnosed with autonomic disorder (START2): a local Russian experience with the use of the Russian version of The Four-Dimensional Symptom Questionnaire (4DSQ). An intermediate analysis. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2015;115(5):27-33. (In Russ.) https://doi.org/10.17116/jnevro20151155127-33
Younus M, Labellarte MJ. Insomnia in children: when are hypnotics indicated? Paediatr Drugs. 2002;4(6):391-403. https://doi.org/10.2165/00128072-200204060-00006
Bailey MA, Saraswatula A, Dale G, Softley L. Paediatric sedation for imaging is safe and effective in a district general hospital. Br J Radiol. 2016;89(1061):20150483. https://doi.org/10.1259/bjr.20150483
François M, Teissier N, Barthod G, Nasra Y. Sedation for children 2 to 5 years of age undergoing auditory brainstem response and auditory steady state responses recordings. Int J Audiol. 2012;51(4):282-286. https://doi.org/10.3109/14992027.2011.601469
Hartz I, Skurtveit S, Steffenak AK, Karlstad Ø, Handal M. Psychotropic drug use among 0-17 year olds during 2004—2014: a nationwide prescription database study. BMC Psychiatry. 2016;16:12. https://doi.org/10.1186/s12888-016-0716-x